No monitoring and measurement effort will be more important to the long-term health of communities than understanding and ...

This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating a 34-day-plus record set ...

NEW YORK CITY (WABC) -- President Donald Trump took to social media on Monday, saying that he will try once more to kill New York City's congestion pricing program. In a post to Truth Social, the ...

DENVER — Colorado has become the first state in the nation to implement a prescription drug price cap, targeting Enbrel, an expensive injectable medication used to treat several autoimmune conditions.

The Trump administration has approved eight drugmakers' rebate plans for a controversial 340B drug discount pilot program that kicks off Jan. 1. The 340B Rebate Model Pilot Program, unveiled this ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

HRSA's 340B Rebate Model Pilot Program includes nine drugs from specific manufacturers, starting January 1, 2026. The pilot program aims to develop future models consistent with the 340B statute and ...

Dan Crippen was the director of the Congressional Budget Office from 1999 to 2003. In its first report on the 340B drug discount program's effect on the budget, the Congressional Budget Office ...

One reason libertarians don’t trust the government is because so many well-intentioned government programs end up either making things worse for the supposed beneficiaries, enriching wealthy and ...

The US Department of Health and Human Services approved select drugmakers’ proposals to discount medicines through rebates under a federal drug program, greenlighting plans that will change how ...

Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known as the 340B drug pricing program — say they are closing in on legislation ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers. Watch the news briefing by ...